The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 1, p. 12, doi. 10.1038/cgt.2013.83
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2014 AND VI 21 AND IP 1
Results: 6
1
2
Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 1, p. 38, doi. 10.1038/cgt.2013.81
- By:
- Publication type:
- Article
3
Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 1, p. 24, doi. 10.1038/cgt.2013.78
- By:
- Publication type:
- Article
4
Combination of adenoviruses expressing melanoma differentiation-associated gene-7 and chemotherapeutic agents produces enhanced cytotoxicity on esophageal carcinoma.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 1, p. 31, doi. 10.1038/cgt.2013.79
- By:
- Publication type:
- Article
5
Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 1, p. 2, doi. 10.1038/cgt.2013.77
- By:
- Publication type:
- Article
6
New horizons for cancer gene therapy.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 1, p. 1, doi. 10.1038/cgt.2013.80
- By:
- Publication type:
- Article